STAT has a blockbuster team of reporters covering health care politics and policy out of Washington, D.C., bringing you all the latest news from the halls of Capitol Hill, from the White House podium, and from inside key agencies like the FDA, HHS, CDC, and NIH. They focus on breaking news, investigations, and features about the ways policymakers’ decisions affect the pharma, biotech, hospitals, insurance, health tech and medical device industries — and how those industries, in turn, are working hard and spending big to affect policy, too.
The team is covering everything from drug pricing to Medicare regulation. We’re tracking major politicians’ health- and science-focused campaign promises and key Supreme Court decisions that affect the U.S. health care landscape.
To get the latest health care politics and policy news delivered to your inbox, sign up for our free, twice-weekly D.C. Diagnosis newsletter. And subscribe to STAT+ for inside intelligence on all these issues and more.
Republicans advanced a bill that would bar health agencies from using a controversial metric known as quality-adjusted life years, or QALYs.
Read The Story
Proposals to cut Medicaid should be off the table because of the essential care it allows more than 90 million Americans to access.
Read The Story
The FDA is supposed to police the food and drug supply. But it's easy to find illegal products — including in the FDA’s own backyard.
Read The Story
Last wrote "Is there $21 billion left for Covid response, or $5 billion? The White House is using fuzzy math"
Rachel's Profile
Last wrote "Texas judge strikes down major Obamacare provision protecting preventive care"
Sarah's Profile
Last wrote "Biden administration goes easy on Medicare Advantage insurers after intense industry lobbying"
John's Profile
advertisement
